CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Colesevelam hydrochloride

Last Updated: April 27, 2012
Result type: Reports
Project Number: SR0274-000
Product Line: Reimbursement Review

Generic Name: Colesevelam hydrochloride

Brand Name: Lodalis

Manufacturer: Valeant Canada LP

Therapeutic Area: Hypercholesterolemia

Indications: Hypercholesterolemia

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: December 19, 2012

Recommendation Type: Do not list at the submitted price